Advanced Medical Care’s investment project involves the construction of a new facility for the production of saline solution and medical supplies, including vacuum blood collection tubes for blood sampling, transport and testing. The project represents a planned investment of EUR 7 million and is expected to create 35 new jobs.
Radev presented Advanced Medical Care with an investment certificate. “This is a strong sign that Bulgarian entrepreneurs are beginning to truly believe in the consistency of our government’s policies, because we have made it clear that Bulgarian investors are the most important investors for us,” Radev said.
“A plant funded entirely by Bulgarian investment will rise here, in a strategic sector, healthcare,” the Prime Minister added. He noted that saline solutions currently used in Bulgarian hospitals are transported from thousands of kilometres away. Radev stressed that healthcare is a strategic priority for the government.
Advanced Medical Care manager Iliyan Iliev told journalists that the company will produce saline solutions, without which hospitals cannot function for even a single day. These solutions are currently supplied mainly from Spain, he added. Against the backdrop of the current crisis with fuel, the transporting of water, and the difficulties companies face when relying on foreign investors, the company decided to invest in production, Iliev said.
Health Minister Katya Ivkova told journalists after the opening ceremony that the construction of facilities for the production of saline solutions and medical supplies strengthens national security. “Saline solutions and blood sample supplies are essential for any healthcare facility. Indeed, there has recently even been a decline in the distribution of such products on our market. So building production capacity at a national level also strengthens the country’s national security,” Ivkova said. According to her, this contributes to the development the country’s competitiveness. “Such solutions are needed not only for our own territory, but also for other EU Member States, as a decline in the market for saline solutions is also being observed there,” Ivkova added.
The facility will be built on the company’s own 18,707 sq.m. plot. The first phase will include an administrative building and a 5,200 sq.m. production hall. According to the Trakia Economic Zone, the facility will feature automated and robotic filling and packaging lines, as well as closed-loop systems for water distillation and the mixing of pharmaceutical products.
Production will target both the Bulgarian market and customers in the European Union and Serbia. The facility is expected to become operational in 2027, with full production capacity scheduled to be reached by 2029.
The investment will create new manufacturing capacity in Bulgaria, generate jobs and contribute to the development of the country’s pharmaceutical and medical industries, the Trakia Economic Zone said.
